Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Phar...
FDA Recall #D-0469-2024 — Class III — April 9, 2024
Product Description
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Reason for Recall
Cross Contamination with Other Products
Recalling Firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — Tokushima, N/A
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
N/A
Distribution
USA nationwide.
Code Information
Lot # APS00423A, Exp 07/31/2025; APS00222A, Exp 11/30/2024
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated